ID

19065

Beschreibung

A Study of Pertuzumab in Participants With Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02480010

Link

https://clinicaltrials.gov/show/NCT02480010

Stichworte

Versionen (1)
  1. 02.12.16 02.12.16 -
Hochgeladen am

2. Dezember 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Prostate Cancer DRKS00010313 NCT02480010

Englisch

Eligibility Prostate Cancer NCT02480010

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
adults greater than (>) 18 years of age
Beschreibung

Adult | Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0001779
histologically documented adenocarcinoma of the prostate resistant to hormone therapy, progressed at 4 to 6 weeks following anti-androgen withdrawal
Beschreibung

Adenocarcinoma of prostate Hormone Therapy Resistant | Androgen Antagonists Withdrawal | Disease Progression

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0007112
UMLS CUI [1,2]
C0279025
UMLS CUI [1,3]
C0332325
UMLS CUI [2,1]
C0002842
UMLS CUI [2,2]
C2349954
UMLS CUI [3]
C0242656
prostate-specific antigen (psa) values at least 20 ng/ml among those with asymptomatic or mildly symptomatic disease
Beschreibung

Prostate specific antigen measurement Asymptomatic Disease | Prostate specific antigen measurement Disease Symptomatic Mild

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0201544
UMLS CUI [1,2]
C2936329
UMLS CUI [2,1]
C0201544
UMLS CUI [2,2]
C0012634
UMLS CUI [2,3]
C0231220
UMLS CUI [2,4]
C2945599
karnofsky performance status (kps) at least 80 percent (%)
Beschreibung

Karnofsky Performance Status

Datentyp

boolean

Alias
UMLS CUI [1]
C0206065
castrate testosterone less than (<) 50 ng/dl
Beschreibung

Castrated male Testosterone measurement

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1319065
UMLS CUI [1,2]
C0523912
life expectancy at least 12 weeks
Beschreibung

Life Expectancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0023671
left ventricular ejection fraction (lvef) at least 50%
Beschreibung

Left ventricular ejection fraction

Datentyp

boolean

Alias
UMLS CUI [1]
C0428772
adequate hematologic, hepatic, and renal function
Beschreibung

Hematologic function | Liver function | Renal function

Datentyp

boolean

Alias
UMLS CUI [1]
C0221130
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0232804
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior chemotherapy, radionucleotide therapy, or immunotherapy for prostate cancer
Beschreibung

Chemotherapy Prostate carcinoma | Immunotherapy Prostate carcinoma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0600139
UMLS CUI [2,1]
C0021083
UMLS CUI [2,2]
C0600139
systemic corticosteroids within 1 month prior to screening
Beschreibung

Adrenal Cortex Hormones Systemic

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C0205373
bisphosphonates within 6 months, narcotic analgesics within 2 weeks, or any investigational agent with 28 days of study drug
Beschreibung

Diphosphonates | Narcotic Analgesics | Investigational New Drugs

Datentyp

boolean

Alias
UMLS CUI [1]
C0012544
UMLS CUI [2]
C0027409
UMLS CUI [3]
C0013230
prior cumulative doxorubicin dose of > 360 mg/m^2 or equivalent
Beschreibung

Doxorubicin Cumulative Dose

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013089
UMLS CUI [1,2]
C2986497
central nervous system (cns) or pulmonary metastases
Beschreibung

CNS metastases | Secondary malignant neoplasm of lung

Datentyp

boolean

Alias
UMLS CUI [1]
C0686377
UMLS CUI [2]
C0153676
other malignancies, except adequately treated basal or squamous cell skin cancer
Beschreibung

Malignant Neoplasms | Basal cell carcinoma Treated | Squamous cell carcinoma of skin Treated

Datentyp

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C0007117
UMLS CUI [2,2]
C1522326
UMLS CUI [3,1]
C0553723
UMLS CUI [3,2]
C1522326
significant cardiovascular disease
Beschreibung

Cardiovascular Disease Significant

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0007222
UMLS CUI [1,2]
C0750502
active/uncontrolled concurrent illness or infection
Beschreibung

Comorbidity Uncontrolled | Communicable Disease Uncontrolled

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0009450
UMLS CUI [2,2]
C0205318
major surgery or traumatic injury within 4 weeks of study drug
Beschreibung

major surgery | Traumatic injury

Datentyp

boolean

Alias
UMLS CUI [1]
C0679637
UMLS CUI [2]
C3263723
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Prostate Cancer NCT02480010

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Age
Item
adults greater than (>) 18 years of age
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Adenocarcinoma of prostate Hormone Therapy Resistant | Androgen Antagonists Withdrawal | Disease Progression
Item
histologically documented adenocarcinoma of the prostate resistant to hormone therapy, progressed at 4 to 6 weeks following anti-androgen withdrawal
boolean
C0007112 (UMLS CUI [1,1])
C0279025 (UMLS CUI [1,2])
C0332325 (UMLS CUI [1,3])
C0002842 (UMLS CUI [2,1])
C2349954 (UMLS CUI [2,2])
C0242656 (UMLS CUI [3])
Prostate specific antigen measurement Asymptomatic Disease | Prostate specific antigen measurement Disease Symptomatic Mild
Item
prostate-specific antigen (psa) values at least 20 ng/ml among those with asymptomatic or mildly symptomatic disease
boolean
C0201544 (UMLS CUI [1,1])
C2936329 (UMLS CUI [1,2])
C0201544 (UMLS CUI [2,1])
C0012634 (UMLS CUI [2,2])
C0231220 (UMLS CUI [2,3])
C2945599 (UMLS CUI [2,4])
Karnofsky Performance Status
Item
karnofsky performance status (kps) at least 80 percent (%)
boolean
C0206065 (UMLS CUI [1])
Castrated male Testosterone measurement
Item
castrate testosterone less than (<) 50 ng/dl
boolean
C1319065 (UMLS CUI [1,1])
C0523912 (UMLS CUI [1,2])
Life Expectancy
Item
life expectancy at least 12 weeks
boolean
C0023671 (UMLS CUI [1])
Left ventricular ejection fraction
Item
left ventricular ejection fraction (lvef) at least 50%
boolean
C0428772 (UMLS CUI [1])
Hematologic function | Liver function | Renal function
Item
adequate hematologic, hepatic, and renal function
boolean
C0221130 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Chemotherapy Prostate carcinoma | Immunotherapy Prostate carcinoma
Item
prior chemotherapy, radionucleotide therapy, or immunotherapy for prostate cancer
boolean
C0392920 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
C0021083 (UMLS CUI [2,1])
C0600139 (UMLS CUI [2,2])
Adrenal Cortex Hormones Systemic
Item
systemic corticosteroids within 1 month prior to screening
boolean
C0001617 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
Diphosphonates | Narcotic Analgesics | Investigational New Drugs
Item
bisphosphonates within 6 months, narcotic analgesics within 2 weeks, or any investigational agent with 28 days of study drug
boolean
C0012544 (UMLS CUI [1])
C0027409 (UMLS CUI [2])
C0013230 (UMLS CUI [3])
Doxorubicin Cumulative Dose
Item
prior cumulative doxorubicin dose of > 360 mg/m^2 or equivalent
boolean
C0013089 (UMLS CUI [1,1])
C2986497 (UMLS CUI [1,2])
CNS metastases | Secondary malignant neoplasm of lung
Item
central nervous system (cns) or pulmonary metastases
boolean
C0686377 (UMLS CUI [1])
C0153676 (UMLS CUI [2])
Malignant Neoplasms | Basal cell carcinoma Treated | Squamous cell carcinoma of skin Treated
Item
other malignancies, except adequately treated basal or squamous cell skin cancer
boolean
C0006826 (UMLS CUI [1])
C0007117 (UMLS CUI [2,1])
C1522326 (UMLS CUI [2,2])
C0553723 (UMLS CUI [3,1])
C1522326 (UMLS CUI [3,2])
Cardiovascular Disease Significant
Item
significant cardiovascular disease
boolean
C0007222 (UMLS CUI [1,1])
C0750502 (UMLS CUI [1,2])
Comorbidity Uncontrolled | Communicable Disease Uncontrolled
Item
active/uncontrolled concurrent illness or infection
boolean
C0009488 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0009450 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
major surgery | Traumatic injury
Item
major surgery or traumatic injury within 4 weeks of study drug
boolean
C0679637 (UMLS CUI [1])
C3263723 (UMLS CUI [2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video